- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged Novo Nordisk’s out-of-hours diabetes helpline (for users of its products) improperly incentivised nurses who also worked in NHS clinics. PMCPA…
Roche’s NeoRecormon congress panel/brochure used a “24% dose reduction vs darbepoetin alfa” and Hb target messaging based on retrospective data. PMCPA found…
Daiichi-Sankyo reported that an Olmetec advert previously ruled in breach reappeared after an undertaking not to use it. Panel found failures to…
A pharmacist challenged Sun Pharma’s email claim that ready-to-administer gemcitabine “minimise[s] risk”. PMCPA ruled the claim misleading and not substantiated (Clauses 7.2,…
Complaint about a Gilenya advertisement in a lay publication. PMCPA concluded the matter was outwith the scope of the ABPI Code (2012).…
A member of the public complained about clinical trial disclosure for Halaven. The PMCPA ruled the matter was outwith the scope of…
A PR agency working for Janssen-Cilag offered journalists £200 to attend a NICE appeal hearing. Janssen-Cilag said it was unaware, but the…
Bonviva materials compared monthly vs weekly dosing and claimed 71% patient preference versus alendronate. PMCPA ruled the comparison misleading because Bonviva’s hip-fracture…
Public alleged a GSK rep sold medicine samples privately, leading to an overdose and hospitalisation. GSK showed samples were posted direct to…
MSD complained about a GSK rep letter offering GPs a free Oxford Handbook. Although educational, the Panel ruled the rep-led selection and…
Shire was found to have breached an undertaking after a leavepiece repeated an “80% preferred” claim without explaining why. Other materials were…
A member of the public challenged a Lilly erectile dysfunction TV advert as illegal public promotion. PMCPA found it was disease awareness,…
A PCT prescribing lead challenged a discontinuation leaflet as covertly promoting analogue insulins and making an unreferenced claim. The PMCPA Panel found…
Curaprox complained about a Corsodyl Mint Mouthwash detail aid. The PMCPA recorded the matter as outwith the scope of the Code, with…
Complaint about Novartis tweets for press releases. PMCPA found the matter outwith the scope of the Code; no breach. No appeal and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.